Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 301–350 of 541 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05658003	A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer	active not recruiting	Phase 2	63	Novartis PharmaceuticalsINDUSTRY	1	Mar 23, 2026	clinicaltrials
NCT06018311	Hispanic Adapted and Culturally Relevant Exercising Together(HACER)	active not recruiting	N/A	58	University of ArizonaOTHER	1	Mar 20, 2026